Immediate Impact
14 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Recent Advances in Pyrimidine-Based Drugs
2024 Standout
Works of Vichitra Behel being referenced
Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC
2022
Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Vichitra Behel | 49 | 44 | 31 | 7 | 79 | |
| Ken Mastris | 38 | 33 | 29 | 6 | 81 | |
| Gracemarie Bricalli | 30 | 31 | 29 | 5 | 97 | |
| G.S. Bhattacharyya | 25 | 47 | 42 | 10 | 102 | |
| Goska Leslie | 36 | 39 | 23 | 5 | 104 | |
| Alana Little | 37 | 91 | 26 | 11 | 166 | |
| Sandeep H. Mashru | 53 | 69 | 20 | 6 | 94 | |
| Petra Flygare | 34 | 37 | 14 | 7 | 70 | |
| Oliver A. Sartor | 38 | 31 | 27 | 10 | 87 | |
| Raquel von Schumann | 20 | 54 | 55 | 12 | 75 | |
| Peter George | 14 | 34 | 37 | 9 | 78 |
All Works
Login with ORCID to disown or claim papers
Loading papers...